home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
press releases
03/01/2024
PainReform Provides Year-End Business Update
read more
01/03/2024
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
read more
12/26/2023
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds
read more
11/15/2023
PainReform Provides Business Update for the Third Quarter of 2023
read more
09/11/2023
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trialto Evaluate PRF-110 in Patients Undergoing Bunionectomy SurgeryFollowing Positive FDA Review of Drug Master File
read more
09/07/2023
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary
read more